A Phase 2 Randomized Double-blind Study of Relatlimab plus Nivolumab in Combination with Chemotherapy vs. Nivolumab in Combination with Chemotherapy as First Line Treatment for Participants with Stage
Clinical Trial Grant
Awarded By
Bristol-Myers Squibb Company
Start Date
May 26, 2021
End Date
February 20, 2024
Awarded By
Bristol-Myers Squibb Company
Start Date
May 26, 2021
End Date
February 20, 2024